As certain hedge fund managers appear to push a "hedge fund" name change, will UBS change the name of its monthly publication . . .
SORRY! This content is exclusively for paying members. If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.
|
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.
When evaluating the competitive advantage of a data-based analytics business, three important questions come to mind: 1) Is the data proprietary? 2) Are the insights from the data critical?... Read More
The following are the notes from Maureen Farrell, Matt Levine and Josh Wolfe's presentation at UC Berkeley's 2020 Virtual Fraud Fest Conference. See our full coverage here. Berkeley’s annual “Fraud... Read More
Rough notes of Which Hedge Fund Strategies Protect Capital During a Market Sell Off and What is the Future of the Hedge Fund Industry panels from the Gaining The... Read More
Fed Policies - We Are Headed Toward A Cashless Society? by Thomas J. DiLorenzo, Mises Institute In this article, Claudio Grass, Managing Director at Global Gold Switzerland, talks to economist... Read More
The music business is starting to think the next big thing is just a computer algorithm away Discovering new music talent like James Bay, this year's tipped breakthrough act whose... Read More
On a day when none other than the Financial Times runs a headline that highlights central bank “distortion” in Japanese stock markets, a related event is noted. Just before... Read More
Is it odd that someone so close to the managed futures industry fell behind Bill Gross in establishing a quantitative investment product? Is Jeffrey Gundlach following in the footsteps of Bill Gross?... Read More
The inside story at Allergan is now firmly public, as the company’s plans to divest itself of certain product categories and acquire another firm were confirmed over the weekend. What... Read More
China's Yuan Devaluation: What You Need To Know by Brad McMillan, Commonwealth Financial Network Some mornings I wake up and wonder what I should blog about. Not today. Looking at... Read More
By Steve Blumenthal “We live at a time where the unthinkable has become common.” — B. Scott Minerd, Managing Partner, Guggenheim Partners Do you remember the story book The Little Engine That... Read More
